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Introduction
The T cell receptor is made up of multiple proteins that transduce a signal (antigen/MHC) received at the surface ofthe cell to the nucleus. There are multiple second messenger pathways activated after T cell receptor stimulation, including the triggering ofcalcium fluxes, activation ofprotein kinase C, and the induction of several tyrosine kinases (for review see references [1] [2] [3] [4] [5] . These changes can then affect more downstream events, particularly the increased transcription ofcertain activation-related genes and cell proliferation (1) (2) (3) (4) (5) (6) (7) . Several reports demonstrate that mitogen-associated protein kinase (MAPK)' under-goes tyrosine as well as threonine phosphorylation, which results in its activation after T cell receptor stimulation (8) (9) (10) (11) (12) . It is thought that MAPK, a serine/threonine kinase, is one ofthe intermediates in the transduction pathway leading to the increase in gene transcription and proliferation (13) (14) (15) (16) .
MEK (MAPK or ERK kinase), which lies directly upstream of MAPK in this cascade, has recently been characterized in several systems. This dual-specificity kinase is capable of activating MAPK and has been suggested to be a convergence point in the MAPK regulatory network (17) (18) (19) . To date, two distinct mechanisms have been proposed to activate MEK (20) (21) (22) (23) (24) . One pathway involves the Ras-dependent activation of Raf-1 kinase (21) (22) (23) (24) . The second pathway involves the activation of MEK kinase (20) . Little is known about the regulation of MEK kinase except, like Raf-1, it is capable of activating MEK (20) .
We determined if the Ras/Raf-1 /MEK cascade has a role in anti-CD3-induced activation of MAPK in T lymphocytes. In addition, we demonstrated the ability of anti-CD3 to activate p9o0hk since MAPK has the ability to phosphorylate and activate this important regulatory protein (25) . After addition ofeither anti-CD3 or phorbol myristate acetate (PMA) we now report increases in Ras, Raf-1 kinase, and MEK activities. In addition, we show the concurrent activation of both MAPK and p9Orhk. We propose that Ras-dependent activation of Raf-1 and MEK is responsible for the stimulation of MAPK and p9Orsk in T cells activated by anti-CD3 or PMA.
Methods
Cells and reagents. The human T lymphocyte cell line Jurkat was obtained from American Type Culture Collection (Rockville, MD). The cells were maintained in RPMI 1640 (GIBCO, Grand Island, NY) supplemented with 10% FCS (Hyclone, Logan, UT), 50 U/ml penicillin-streptomycin, and 2 mM glutamine at 370C and 7% CO2. Anti-CD3 (OKT3) was obtained from Ortho Pharmaceutical Corp. (Raritan, NJ); PMA, protein A-Sepharose beads (PAS), and purified rabbit IgG were purchased from Sigma Chemical Co. (St. Louis, MO). Monoclonal mouse anti-MAPK antibody was purchased from Zymed (South San Francisco, CA). Polyclonal rabbit anti-MEK antibody was obtained from Transduction Laboratories (Lexington, KY) and rabbit polyclonal anti-Raf-1 was purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Affinity purified polyclonal rabbit anti-mouse rsk I S6 kinase antibody was purchased from Upstate Biotechnology, Inc. (Lake Placid, NY). The recombinant wild-type and kinase-inactive forms of MEK and MAPK were expressed and purified as described (26) .
Measurement of Raf-l kinase activity. Measurement of Raf-1 kinase activity was performed as previously described (26, 27) . Briefly, 1.2 x I07 Jurkat cells were stimulated in RPMI 1640 using the appropriate conditions. They were then lysed in RIPA ( 1% sodium deoxycholate, 1% Triton X-100, 0.1% SDS, 150 mM NaCl, 50 mM Tris (pH 7.2), 1 mM PMSF, 2 ,g/ml aprotinin, 50 uM leupeptin, 200 uM Na3VO4, 50 mM NaF). Lysates were precleared by PAS beads and purified polyclonal anti-Raf-l antibody ( 1:100) was added to the lysates. The immune complexes were collected by PAS beads and kinase assays were performed using kinase-inactive MEK (KMMEK) as a substrate. The purified recombinant KMMEK runs as a 50-kD protein because of the six histidine tag and additional amino acids from the RSET expression vector (Invitrogen, La Jolla, CA). The proteins were separated by 10% SDS-PAGE and transferred to a nitrocellulose membrane. The membranes were probed using the same anti-Raf-1 antibody with an alkaline phosphatase visualization system (protoblot APsystem; Promega Biotec, Madison, WI) and subjected to autoradiography. Quantitation of 32P incorporation into the recombinant kinase-inactive MEK was performed with a phosphor-imager (Molecular Dynamics, Sunnyvale, CA).
Measurement ofRas activation. Cells (5 X 106) were labeled with [32p] orthophosphate for 16 h before stimulation. Ras was immunoprecipitated using the Y 13-259 anti-Ras antibody and GTP was separated from GDP by thin layer chromatography as previously described (28) . The radiolabeled nucleotides were visualized by autoradiography and quantitated with a phosphor-imager. Data are presented as GTP/GTP + (1.5)GDP ratios (28) .
MEK activity measurements. Measurements of MEK activity were performed as previously described (26, 27) . After the different treatments, 4-5 x 10' cells were lysed in 600 Al lysis buffer. After lysis, the samples were centrifuged and 500 ,ul ofthe postnuclear cell lysates were fractionated on a mono-S HR 5/5 FPLC column (Pharmacia, Uppsala, Sweden). The fractions were assayed for kinase activity in a coupled system containing recombinant wild-type MAPK (ERK2, 42-kD polypeptide) and epidermal growth factor receptor peptide (EGFR"2.681) (26, 27) . Simultaneously, some of the fractions were also assayed for their ability to phosphorylate recombinant, kinase-inactive MAPK (KMMAPK) (26, 27) . Phosphorylated KMMAPK (which also runs as a 50-kD protein) was separated on a 10% SDS-PAGE gel and transferred onto nitrocellulose membranes. Phosphorylation of KMMAPK was then visualized by autoradiography and quantitated by phosphor-imager. The assay was performed using enzyme, substrate, and time so that the activity measured is linearly related to enzyme concentration.
Immunoblotting. After different treatments, 2.5 X 106 Jurkat cells were lysed in RIPA buffer and immunoblotted as previously described (29) . Briefly, samples were electrophoresed through 10% SDS-PAGE gels and proteins were transferred to nitrocellulose membranes. Membranes were incubated (2 h) in blocking buffer; monoclonal anti-MAPK (1:2,000) or anti-p90 (1:10,000) were then added to the blocking buffer and blots were incubated for an additional 2 h at room temperature. The blots were washed in TBST (25 mM Tris-HCl (pH 8.0), 125 mM NaCl, 0.025% Tween 20) and incubated with alkaline phosphatase-conjugated goat anti-rabbit Ig ( 1:10,000 in TBST; Promega), for the anti-p90= blots, or alkaline phosphatase-conjugated goat anti-mouse Ig ( 1:10,000 in TBST; Promega) for the MAPK blots.
p9O'k activity measurements. p90 ribosomal S6 kinase activity was detected as previously described (30, 31 ) . Cells (2.5 x 106) were stimulated and p90 was immunoprecipitated from postnuclear lystes using polyclonal rabbit anti-mouse rsk I S6 kinase antibody (32) stopped by the addition of EDTA, and the supernatant (25 zd) was applied to filter paper (P8 1; Whatman Inc., Clifton, NJ). Filter papers were washed and radioactivity bound to the filter papers was determined by liquid scintillation counting. Parallel samples were immunoprecipitated in the same manner and resuspended in sample buffer and immunoblotted using the immunoprecipitating antibody. The assay was performed using enzyme, substrate, and time so that the activity measured is linearly related to enzyme concentration.
Results and Discussion
Two pathways leading to the activation of MAPK have been described in other cell types (20) (21) (22) (23) (24) . We determined if the triggering of one of these pathways occurred after stimulation of T cells through the T-cell receptor. Because of recent advances we were able to measure the specific kinase activity of Raf-1 towards a downstream substrate, MEK (20, 26) , in the proposed pathway, as well as measuring the ability of cellular MEK to phosphorylate and activate recombinant MAPK in activated T cells. In this report we demonstrate the activation of the Ras/Raf-l/MEK/MAPK/p90' pathway in T cells stimulated after ligation of the T-cell receptor.
Activated Raf-1 kinase has been proposed to phosphorylate and activate MEK (21) (22) (23) (24) . A recombinant kinase inactive MEK (KMMEK) that lacks kinase and autophosphorylation activities because of mutation of lysine97 to methionine in the ATP binding site was recently developed (26, 27) . This recombinant protein can be used as a substrate to measure the ability of Raf-1 to phosphorylate this enzyme. When Jurkat cells were stimulated with an antibody directed towards the CD3 complex, the activation of Raf-1 kinase activity (towards KMMEK) in these cells was rapid, detectable within 1 min, and peaked at -2.5 min (Fig. 1 A) . The protein kinase C activator, PMA, was able to induce comparable levels of Raf-1 kinase activity. When immunoprecipitations were performed using nonspecific rabbit Ig to control for nonspecific interactions by the anti-Raf-1 antibody, very little kinase activity was precipitated. Lane I in Fig. 1 A contains a cell-free sample of recombinant wild-type MEK (which has the capacity for autophosphorylation). This was used to locate the substrate (KMMEK) and control for the kinase reaction. Quantitation of the same experiment by phosphor-imager is shown in Fig. 1 B, revealing an -12-fold increase in Raf-l kinase activity 2.5 min after stimulation of Jurkat cells by anti-CD3. The PMAinduced stimulation of Raf-1 was in a similar range, an -16-fold increase 20 min after stimulation. To ensure that our antibody to Raf-1 kinase immunoprecipitated similar amounts of Raf-1 under all treatment conditions, we used the same antibody to probe the immunoprecipitates used in the kinase assay (Fig. 1 C) . Besides the immunoglobulin bands, a single band (Raf-1), was observed just below the 80-kD marker. Raf-1 in the immunoprecipitates was somewhat variable, but the increased activity was clearly related to activation of the enzyme and not increased amounts of enzyme in the immunoprecipitate. No bands were observed when rabbit IgG was used for the immunoprecipitations (Fig. 1 C, lane 9 ).
These data demonstrate that both anti-CD3 and PMA are able to induce the kinase activities of Raf-1 towards MEK in T cells. The hyperphosphorylation and increased kinase activities of Raf-1 after T cell receptor activation has been previously reported (33) , however, this is the first report in T cells that shows that Raf-1, immunoprecipitated from activated T cells, is capable of phosphorylating another kinase (MEK) and participating in a signaling program.
In several systems, the Ras-dependent activation of Raf-1 has been described (22) (23) (24) 34 PMA or anti-CD3, we used both a direct and indirect system. In both systems we fractionated lysates from Jurkat cells using fast phase liquid chromatography and a mono-S column. The proteins were eluted off the mono-S column using a salt gradient and the different fractions were examined for the ability to phosphorylate (direct method) or activate (indirect method) recombinant MAPK. The advantage of the direct method was that it enabled us to examine changes in the phosphorylation status ofMAPK induced by the different fractions. The advantage ofthe indirect method was that it allowed examination of MAPK activity presumably induced by the changes in phosphorylation.
In the direct approach the fractions from the column were assessed for their ability to phosphorylate recombinant kinaseinactive MAPK (KMMAPK). Like KMMEK this protein has also lost the ability to autophosphorylate. Fig. 3 A shows the results of in vitro kinase assays followed by SDS-PAGE and autoradiography using the different fractions. Kinase activity towards KMMAPK in fractions 10-12 from anti-CD3 (middle) and PMA (bottom)-stimulated Jurkat cells was greatly increased when compared with unstimulated cells (top). Quantitation of these results by the phospho-imager is shown in Fig. 3 (20, 27) . The increases in EGFR662-681 phosphorylation that elute off the column at higher salt concentrations are the result ofthe activation ofa cellular MEK that has activated the recombinant MAPK (20, 27) . Anti-CD3 (2. When Jurkat cells were stimulated with anti-CD3 and PMA and immunoblotting was performed using a monoclonal anti-ERKl antibody that recognizes the p42 form ofMAPK in our system, both anti-CD3 and PMA induced the appearance of a second, lower mobility species of MAPK (Fig. 4 A) . This lower mobility form of MAPK is thought to represent the activated form of this enzyme (35, 36) . p9O' is thought to be directly phosphorylated and activated by MAPK. We determined the activation status of p9Orsk after the triggering ofthis Ras/ Raf-I /MEK/MAPK pathway. When p90k was immunoprecipitated and the ability of these immunoprecipitates to phosphorylate the S6 peptide were monitored, significant increases were observed after either anti-CD3 (fourfold) or PMA (sevenfold) stimulation (Fig. 4 B) . We did not observe these increases in S6 kinase activity when purified mouse IgG was used to immunoprecipitate lysates from PMA-stimulated cells (Fig. 4 B) . To ensure that our immunoprecipitating antibody was precipitating equal amounts ofp9O0 from each treatment group, immunoblots of the immunoprecipitates were performed using this antibody. As can be clearly seen in Fig. 4 C, equal amounts of p9O0 were precipitated from all the cell treatment groups. The altered migration of p9O0 in these gels after stimulation with either anti-CD3 or PMA is likely due to the phosphorylation of this enzyme. These data demonstrate that the activation of MAPK and an event subsequent to MAPK activation, p90Th activation, occurs in Jurkat cells stimulated under conditions that lead to Ras, Raf-1, and MEK activation. (Fig. 5 In Jurkat and peripheral blood lymphocytes, PKC will mediate the activation of Ras (28). Nel and coworkers (11) reported that the activation of MAPK by anti-CD3 in T cells is only partially regulated by PKC. This suggests that Ras activation is occurring via PKC-dependent and PKC-independent pathways. One possibility for the PKC-independent activation ofRas is the utilization ofVav. Vav has been shown to increase the release ofguanine nucleotides, which would potentially result in the activation of Ras (37) . Vav has also been shown to be activated by p56 Ick, an important kinase that is associated with the T-cell receptor and is thought to be rapidly activated after receptor ligation (37, 38) . In this pathway, stimulation of the T-cell receptor and the subsequent activation of p561ck could result in the activation of a Vav/Ras/Raf-l/MEK/ MAPK/p90i cascade. In epithelial cells, stimulation of the EGF receptor is thought to mediate the activation of Ras via the growth factor receptor-binding protein (GRB2) and the mammalian son ofsevenless gene protein (mSOS). These proteins are associated in the cytoplasm and bind to a phosphate group on the receptor (39, 40) . This binding leads to the activation of Ras by inducing the exchange of GDP for GTP (39, 40) . Although the role for GRB2 or mSOS in anti-CD3-induced signaling remains to be determined, it is possible that they are involved because elements in the T cell receptor complex undergo tyrosine phosphorylation after cross-linking (1) (2) (3) (4) (5) . Although it is obvious from our results that activation of PKC by PMA can mediate the triggering of the Ras/Raf-l / MEK/MAPK/p90S' cascade, we have not determined the relative contribution of a PKC-driven pathway to the other potential pathways (Vav and GRB2/mSos) leading to MAPK activation.
Recently, a novel MEK kinase has been described that is different from Raf-1 and homologous to the yeast STE 11 gene product (20) . We do not know ifthis MEK kinase is activated in T lymphocytes; it is possible that both Ras-dependent activation of Raf-1 and the activation of MEK kinase occur after anti-CD3 and/or PMA stimulation in T lymphocytes. We do know, however, that Raf-1 is activated and, when immunoprecipitated, it will phosphorylate MEK. MEK is also activated under these conditions, as shown by its ability to phosphorylate and activate MAPK in vitro.
Although v-rafis capable of inducing cellular proliferation in transfected cells (41 ), it is premature to conclude that this is through the activation ofMAPK, because Raf-I may have substrates other than MEK involved in proliferative responses. Similarly, the role of MAPK activation in T cell proliferation has not been fully defined. Activated MAPK is capable ofphosphorylating and activating a number of transcription factors (23, 42) . In addition to p9O k, MAPK will phosphorylate transcription factors such as c-jun, c-myc, and p62T in vitro ( 14, 15, 42) . It is likely that the cascade of Ras/Raf-1 /MEK resulting in MAPK 
